BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akhter MS, Barabutis N. Suppression of reactive oxygen species in endothelial cells by an antagonist of growth hormone-releasing hormone. J Biochem Mol Toxicol 2021;:e22879. [PMID: 34369038 DOI: 10.1002/jbt.22879] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Barabutis N, Akhter MS, Kubra KT, Jackson K. Growth Hormone-Releasing Hormone in Endothelial Inflammation. Endocrinology 2022;164:bqac209. [PMID: 36503995 DOI: 10.1210/endocr/bqac209] [Reference Citation Analysis]
2 Kubra K, Akhter MS, Apperley K, Barabutis N. Growth Hormone-Releasing Hormone Antagonist JV-1-36 Suppresses Reactive Oxygen Species Generation in A549 Lung Cancer Cells. Endocrines 2022;3:813-820. [DOI: 10.3390/endocrines3040067] [Reference Citation Analysis]
3 Akhter MS, Kubra KT, Barabutis N. Protective effects of GHRH antagonists against hydrogen peroxide-induced lung endothelial barrier disruption. Endocrine 2022. [PMID: 36261700 DOI: 10.1007/s12020-022-03226-1] [Reference Citation Analysis]
4 Akhter MS, Kubra KT, Uddin MA, Jois S, Barabutis N. An antagonist of growth hormone-releasing hormone protects against LPS-induced increase of bronchoalveolar lavage fluid protein concentration. Inflamm Res 2022. [PMID: 34993559 DOI: 10.1007/s00011-021-01531-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kubra KT, Uddin MA, Akhter MS, Leo AJ, Siejka A, Barabutis N. P53 mediates the protective effects of metformin in inflamed lung endothelial cells. Int Immunopharmacol 2021;:108367. [PMID: 34794886 DOI: 10.1016/j.intimp.2021.108367] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]